Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay
Go back to Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay| Waters Corporation (NYSE: WAT) | Delayed: 358.24 +2.80 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $355.44 | 52 Week High | $162.53 | |||
| Open | $355.90 | 52 Week Low | $112.00 | |||
| Day High | $360.24 | P/E | 68.89 | |||
| Day Low | $353.53 | EPS | $5.20 | |||
| Volume | 632,409 | |||||
